AnaPath Research is a global CRO based near Barcelona, providing research and development services for various industries including pharmaceuticals, biotechnology, agriculture, and chemistry. This article investigates and summarizes the company's features and information on its disease models.
At AnaPath Research, to confirm the safety of new drug candidates,Supports a wide range of in vivo (in the body) testsWe can handle general repeated-dose toxicity studies, reproductive and developmental toxicity studies, and safety pharmacology studies evaluating the central nervous system and cardiovascular system.A specialized team with extensive experience conducts comprehensive risk assessments from the initial stage.We support the development of pharmaceuticals by doing this.
In addition to low-molecular-weight compounds, recombinant proteins, monoclonal antibodies, gene therapy drugs, and otherProvision of analytical services for biologics (biopharmaceuticals)We are engaged in a wide range of specialized bioanalytical services to meet regulatory requirements. This includes method development and validation for pharmacokinetics (PK) and toxicokinetics (TK), as well as measurement of anti-drug antibodies (ADAs) and quantification of biomarkers.
The company is the standard for conducting drug safety tests.GLP (Good Laboratory Practice) certified facilityand we provide reliable test data. Furthermore,Accreditation from AAALAC, an international animal welfare organizationWe also have strict auditing systems in place, implemented by a quality assurance team with many years of experience, ensuring ethical and appropriate handling.
AnaPath Research is a CRO that conducts studies directly at its own facilities. For safety assessments and toxicity testing, we appropriately select and utilize a diverse range of animal models, from rodents (rats and mice) to non-rodents (dogs, minipigs, and non-human primates), depending on the characteristics of each compound.
While AnaPath Research's official website does not feature specific non-clinical study examples, the company conducts safety evaluation studies for a wide range of compounds.
Due to confidentiality of individual sponsor names and specific development compounds in safety assessment studies, detailed study examples are not disclosed. However, from the era of its predecessor testing facility, the company has decades of experience in conducting GLP-compliant studies across a wide range of fields, including pharmaceuticals, medical devices, and agricultural chemicals, and has a proven track record of contributing to regulatory applications in various countries.
| Address | Barcelona, Spain |
|---|---|
| Tel | +34 93 719 03 61 |
| Website | https://www.anapathresearch.com/ |
In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D.
In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening.
Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.